Medication-Related Quality of Life in Thai Epilepsy Patients

Overview

Journal J Epilepsy Res

Date 2020 Jun 9

PMID 32509550

Authors

Phantipa Sakthong

Bavornpat Suriyapakorn

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: This study aimed to assess medication-related quality of life in Thai patients with epilepsy. The second objective was to evaluate the associations between the medication therapy-related quality of life and patient characteristics.

Methods: This was a cross-sectional study. A convenience sample of 173 outpatients with epilepsy was recruited from a university hospital in Bangkok, Thailand. Inclusion criteria were aged 18 or over who were continuously taking an epileptic drug for at least 3 months, understanding Thai language, and willing to participate in the study. The Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL) was utilized to measure the medication therapy-related quality of life. Pearson's correlation coefficients and stepwise multiple linear regressions were employed to assess the relationships between eight PROMPT-QoL domain scores and patient demographic and clinical characteristics.

Results: Mean age was 36.4±9.5 years and approximately 57% were female. Among eight domains of the PROMPT-QoL, the therapeutic relationships with health care providers and psychological impacts of medication use domains yielded the highest (77.9) and lowest (61.9) mean scores, respectively. Seven out of eight PROMPT-QoL domain scores were considered as moderate-to-good. Age, gender, duration of epilepsy, seizure frequency, and treatment preference were significantly associated with PROMPT-QoL domain scores in multivariate linear regression analyses.

Conclusions: This study showed that Thai patients with epilepsy had moderate-to-good medication therapy-related quality of life. Healthcare providers should pay more attention to patients' psychological impacts of antiepileptic drugs and those with characteristics related to lower medication therapy-related quality of life.

References

Chen H, Tsai Y, Hsi M, Chen J . Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study. Epilepsy Behav. 2016; 58:26-32. DOI: 10.1016/j.yebeh.2016.02.019. View

Sakthong P, Suksanga P, Sakulbumrungsil R, Winit-Watjana W . Development of Patient-reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL): A novel instrument for medication management. Res Social Adm Pharm. 2014; 11(3):315-38. DOI: 10.1016/j.sapharm.2014.10.002. View

Peltzer K, Pengpid S . The use of herbal medicines among chronic disease patients in Thailand: a cross-sectional survey. J Multidiscip Healthc. 2019; 12:573-582. PMC: 6661386. DOI: 10.2147/JMDH.S212953. View

Taylor R, Sander J, Taylor R, Baker G . Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011; 52(12):2168-80. DOI: 10.1111/j.1528-1167.2011.03213.x. View

Devinsky O, Vickrey B, Cramer J, Perrine K, Hermann B, Meador K . Development of the quality of life in epilepsy inventory. Epilepsia. 1995; 36(11):1089-104. DOI: 10.1111/j.1528-1157.1995.tb00467.x. View

Blond B, Detyniecki K, Hirsch L . Assessment of Treatment Side Effects and Quality of Life in People with Epilepsy. Neurol Clin. 2016; 34(2):395-410, viii. DOI: 10.1016/j.ncl.2015.11.002. View

Shakir M, Al-Asadi J . Quality of life and its determinants in people with epilepsy in basrah, iraq. Sultan Qaboos Univ Med J. 2013; 12(4):449-57. PMC: 3523994. View

Puri I, Dash D, Padma M, Tripathi M . Quality of Life and Its Determinants in Adult Drug Refractory Epilepsy Patients Who Were Not Candidates for Epilepsy Surgery: A Correlational Study. J Epilepsy Res. 2019; 8(2):81-86. PMC: 6374533. DOI: 10.14581/jer.18013. View

Melikyan E, Guekht A, Milchakova L, Lebedeva A, Bondareva I, Gusev E . Health-related quality of life in Russian adults with epilepsy: the effect of socio-demographic and clinical factors. Epilepsy Behav. 2012; 25(4):670-5. DOI: 10.1016/j.yebeh.2012.09.042. View

10.

Sakthong P, Chinthammit C, Sukarnjanaset P, Sonsa-Ardjit N, Munpan W . Psychometric Properties of the Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QOL). Value Health Reg Issues. 2017; 12:41-49. DOI: 10.1016/j.vhri.2017.02.003. View

11.

Santos A, Castro-Lima H, Matos M, Brito M . Quality of life among women with epilepsy during their reproductive years. Epilepsy Behav. 2018; 85:10-13. DOI: 10.1016/j.yebeh.2018.04.028. View

12.

Edefonti V, Bravi F, Turner K, Beghi E, Canevini M, Ferraroni M . Health-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian study. BMC Neurol. 2011; 11:33. PMC: 3062600. DOI: 10.1186/1471-2377-11-33. View

13.

Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W . Prevalence of epilepsy in rural Thailand: a population-based study. J Med Assoc Thai. 2002; 85(10):1066-73. View

14.

Sakthong P, Sangthonganotai T . A randomized controlled trial of the impact of pharmacist-led patient-centered pharmaceutical care on patients' medicine therapy-related quality of life. Res Social Adm Pharm. 2017; 14(4):332-339. DOI: 10.1016/j.sapharm.2017.05.001. View